Elix, Inc. is honored to be chosen for one of 19 startups for the pharmaceutical & medical acceleration program ”Blockbuster TOKYO”. The Elix team will focus on “Development of AI drug discovery software centering on property prediction and molecular design” through this program. We are honored and excited to participate in the Blockbuster Tokyo 2019 program, learning from the invaluable mentorship of key industry leaders.

-Press Release
https://prtimes.jp/main/html/rd/p/000000060.000017460.html?fbclid=IwAR1Pzio22UYWdKCd_AFLbdlYi-7JqHGQRVCYkMjEl9Jzvb4c59J0ZGsVKqw